These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25009660)

  • 1. Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy.
    Gezer U; Keskin S; Iğci A; Tükenmez M; Tiryakioğlu D; Cetinkaya M; Dişci R; Dalay N; Eralp Y
    Oncol Lett; 2014 Aug; 8(2):845-848. PubMed ID: 25009660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer.
    Zhu W; Liu M; Fan Y; Ma F; Xu N; Xu B
    Cancer Med; 2018 Sep; 7(9):4420-4433. PubMed ID: 30099860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer.
    Raychaudhuri M; Bronger H; Buchner T; Kiechle M; Weichert W; Avril S
    Breast Cancer Res Treat; 2017 Apr; 162(3):511-521. PubMed ID: 28181130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
    Wu X; Somlo G; Yu Y; Palomares MR; Li AX; Zhou W; Chow A; Yen Y; Rossi JJ; Gao H; Wang J; Yuan YC; Frankel P; Li S; Ashing-Giwa KT; Sun G; Wang Y; Smith R; Robinson K; Ren X; Wang SE
    J Transl Med; 2012 Mar; 10():42. PubMed ID: 22400902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7f and miRNA-126 correlate with reduced cardiotoxicity risk in triple-negative breast cancer patients who underwent neoadjuvant chemotherapy.
    Zhu Z; Li X; Dong H; Ke S; Zheng WH
    Int J Clin Exp Pathol; 2018; 11(10):4987-4995. PubMed ID: 31949575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
    Frères P; Josse C; Bovy N; Boukerroucha M; Struman I; Bours V; Jerusalem G
    J Cell Physiol; 2015 Feb; 230(2):473-81. PubMed ID: 25078559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
    BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients.
    Ibrahim AM; Said MM; Hilal AM; Medhat AM; Abd Elsalam IM
    Tumour Biol; 2020 Oct; 42(10):1010428320963811. PubMed ID: 33028151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.
    Khalighfard S; Alizadeh AM; Irani S; Omranipour R
    Sci Rep; 2018 Dec; 8(1):17981. PubMed ID: 30568292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer.
    Navarro-Manzano E; Luengo-Gil G; González-Conejero R; García-Garre E; García-Martínez E; García-Torralba E; Chaves-Benito A; Vicente V; Ayala de la Peña F
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
    BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
    Tanaka K; Miyata H; Yamasaki M; Sugimura K; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S607-15. PubMed ID: 23838916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
    van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
    Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study.
    Holubekova V; Kolkova Z; Grendar M; Brany D; Dvorska D; Stastny I; Jagelkova M; Zelinova K; Samec M; Liskova A; Laucekova Z; Kudela E; Bobrovska M; Kalman M; Zubor P; Dankova Z
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
    Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
    Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
    Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
    Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies.
    Petrillo M; Zannoni GF; Beltrame L; Martinelli E; DiFeo A; Paracchini L; Craparotta I; Mannarino L; Vizzielli G; Scambia G; D'Incalci M; Romualdi C; Marchini S
    Ann Oncol; 2016 Apr; 27(4):625-34. PubMed ID: 26782955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumour epithelial subtype on circulating microRNAs in breast cancer patients.
    Waters PS; Dwyer RM; Brougham C; Glynn CL; Wall D; Hyland P; Duignan M; McLoughlin M; Newell J; Kerin MJ
    PLoS One; 2014; 9(3):e90605. PubMed ID: 24626163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.